Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared some papers on LinkedIn:
Title: HSP90 buffers deleterious genetic variations in BRCA1
Authors: Brant Gracia, Xing-Han Zhang, Patricia Montes, Tin Chanh Pham, Min Huang, Junjie Chen, and Georgios Ioannis Karras
You can read the Full Article in Molecular Cell.

Title: Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors: A. Zer, M.-J. Ahn, F. Barlesi, L. Bubendorf, D. De Ruysscher, P. Garrido, O. Gautschi, L.E. Hendriks, P.A. Jänne, K.M. Kerr, C. Mascaux, T. Mitsudomi, S. Peters, C. Rolfo, A. Sacher, S. Senan, P. Ugalde, and N.B. Leighl
You can read the Full Article in Annals of Oncology.

Title: ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI)
Authors: M. Aldea, M. Salto-Tellez, A. Marra, R. Umeton, A. Stenzinger, M. Koopman, A. Prelaj, K.L. Kehl, S. Gilbert, M-E Leßmann, J. Lipkova, L. Provenzano, F. Meric-Bernstam, S. Halabi, J. Wu, A. Pellat, K.P.M. Suijkerbuijk, B. Besse, B. Ryll, C. Marchió, M. Crispin-Ortuzar, R. Fehrmann, J. Vibert, D. Ferber, C. Pauli, A. Valachis, Federica Corso, T.J. Brinker, J. Mateo, N. Harbeck, E.C. Winkler, F. Lopez-Rios, R. Perez-Lopez, G. Pentheroudakis, S. Delaloge, C. Benedikt Westphalen, and J.N. Kather
You can read the Full Article in Annals of Oncology.

Title: Belzutifan for Advanced Pheochromocytoma or Paraganglioma
Authors: Camilo Jimenez, Mikkel Andreassen, Alice Durand, Sophie Moog, Andrew Hendifar, Staffan Welin, Francesca Spada, Rohini Sharma, Edward Wolin, Joseph Ruether, Rocio Garcia-Carbonero, Martin Fassnacht, Jaume Capdevila, Jaydira Del Rivero, Othon Iliopoulos, Olivier Huillard, Raymond Jang, Knut Mai, Elena Artamonova, Andreas Hallqvist, Tobias Else, Amos Odeleye-Ajakaye, Alexander Gozman, Girish S. Naik, and Alfredo Berruti
You can read the Full Article in NEJM.

Title: Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane Review
Authors: Vivek Subbiah and Razelle Kurzrock
You can read the Full Article in the Journal of Clinical Oncology.

Title: Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer
Authors: Daniel Kates-Harbeck, Hans Kreipe, Oleg Gluz, Matthias Christgen, Sherko Kuemmel, Monika Graeser, Ulrike Nitz, Sven Mahner, Doris Mayr, Rachel Wuerstlein, Akinori Mitani, Jingbin Zhang, Hans Pinckaers, Gijs Smit, Yi Ren, Songwan Joun, Jacqueline Griffin, Nancy Lin, Felix Feng, Andre Esteva, Ronald Kates, and Nadia Harbeck
You can read the Full Article in JCO Clinical Cancer Informatics.

Title: If Exercise Were a Pill, We’d All Prescribe It to Patients With Cancer. But It’s Not
Authors: Kathryn H. Schmitz and Jennifer A. Ligibel
You can read the Full Article in the Journal of Clinical Oncology.

Title: Lung Cancer Deaths Prevented and Life-Years Gained From Lung Cancer Screening
Authors: Priti Bandi, Rebecca Landy, Jessica Star, Tyler B. Kratzer, Robert A. Smith, and Ahmedin Jemal.
You can read the Full Article in JAMA.

Title: Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer
Authors: Nicholas G. Zaorsky, Yilun Sun, Abdenour Nabid, Almudena Zapatero, Michel Bolla, David Joseph, Philippe Maingon, Araceli Guerrero, Ana Alvarez Gonzalez, Carmen Gonzalez San-Segundo, Maria Ángeles Cabeza Rodríguez, Josep Maria Sole, Agustí Pedro Olivé, Allison Steigler, Luis Souhami, Nathalie Carrier, John G. Armstrong, Charles Gillham, Thomas M. Pisansky, Matthew Schipper, Howard M. Sandler, Jason A. Efstathiou, Colleen Lawton, Theo M. de Reijke, Gerhardt Attard, Soumyajit Roy, Scott C. Morgan, Shawn Malone, William A. Hall, Paul L. Nguyen, Jonathan E. Shoag, Randy A. Vince Jr, Adam Conway, Jorge A. Garcia, Pedro C. Barata, Prateek Mendiratta, Jason R. Brown, Luca Valle, Matthew Rettig, Robert T. Dess, William C. Jackson, Ting Martin, Ma, Angela Y. Jia, Michael Steinberg, Tahmineh Romero, Amar U. Kishan, and Daniel E. Spratt
You can read the Full Article in JAMA Oncology.

Title: Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01
Authors: Shubham Pant, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui-Chuan Sun, Teresa Macarulla, Feng Xie, Jean-Phillippe Metges, Jie’er Ying, John Bridgewater, Myung-Ah Lee, Mohamedtaki A. Tejani, Emerson Y. Chen, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Xiaotian Wu, Yi Zhao, Phillip M. Garfin, Jonathon Gable, and James J. Harding
You can read the Full Article in JAMA Oncology.

Title: A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer
Authors: Edgar Ben-Josef, Andrew M. Lowy
You can read the Full Article in JAMA Oncology.

You can find more posts featuring Vivek Subbiah on OncoDaily.